Display Settings:

Format

Send to:

Choose Destination
    Nat Rev Immunol. 2008 Oct;8(10):788-801.

    Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice.

    Source

    Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA. singera@mail.nih.gov

    Abstract

    Following successful gene rearrangement at alphabeta T-cell receptor (TCR) loci, developing thymocytes express both CD4 and CD8 co-receptors and undergo a life-or-death selection event, which is known as positive selection, to identify cells that express TCRs with potentially useful ligand specificities. Positively selected thymocytes must then differentiate into either CD4(+) helper T cells or CD8(+) cytotoxic T cells, a crucial decision known as CD4/CD8-lineage choice. In this Review, we summarize recent advances in our understanding of the cellular and molecular events involved in lineage-fate decision and discuss them in the context of the major models of CD4/CD8-lineage choice.

    PMID:
    18802443
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2760737
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Figure 1
    Figure 3
    Figure 5
    Figure 2
    Figure 4
    Figure 6

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk